A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different.
Boston Scientific, which is growing in Minnesota, is buying California's Penumbra for $14.5 billion. CEO Mike Mahoney said the deal makes his company a neurovascular leader.
